Atıf Formatları
Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. ÖZKAN And K. FIŞKIN, "Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.," TÜRK HEMATOLOJİ ONKOLOJİ DERGİSİ , vol.13, no.3, pp.125-133, 2003

ÖZKAN, A. And FIŞKIN, K. 2003. Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.. TÜRK HEMATOLOJİ ONKOLOJİ DERGİSİ , vol.13, no.3 , 125-133.

ÖZKAN, A., & FIŞKIN, K., (2003). Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.. TÜRK HEMATOLOJİ ONKOLOJİ DERGİSİ , vol.13, no.3, 125-133.

ÖZKAN, AYSUN, And KAYAHAN FIŞKIN. "Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.," TÜRK HEMATOLOJİ ONKOLOJİ DERGİSİ , vol.13, no.3, 125-133, 2003

ÖZKAN, AYSUN And FIŞKIN, KAYAHAN. "Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.." TÜRK HEMATOLOJİ ONKOLOJİ DERGİSİ , vol.13, no.3, pp.125-133, 2003

ÖZKAN, A. And FIŞKIN, K. (2003) . "Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.." TÜRK HEMATOLOJİ ONKOLOJİ DERGİSİ , vol.13, no.3, pp.125-133.

@article{article, author={AYSUN ÖZKAN And author={KAYAHAN FIŞKIN}, title={Epirubicin-HCI cytotoxicity in non-small cell lung cancer (NSCLC) cells.}, journal={TÜRK HEMATOLOJİ ONKOLOJİ DERGİSİ}, year=2003, pages={125-133} }